12:00 AM
Oct 22, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Preob bone-forming cells: Phase III started

Bone Therapeutics began a double-blind, placebo-controlled, European Phase III trial to evaluate Preob administered percutaneously via a minimally invasive...

Read the full 75 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >